BBX Logo Beta

--

AI-powered drug discovery company Isomorphic Labs has raised $5 billion in Series C funding. The round was led by Greenoaks and Sequoia Capital, with renewed participation from Alphabet. Isomorphic Labs will use the funds to expand its drug design engine, IsoDDE, build operational capabilities to drive drug candidates into clinical trials, and support its own and collaborative drug development projects. Andreessen Horowitz, Thrive Capital, GV Capital, and Temasek also participated in the funding round.

Loading...